Processa Pharmaceuticals
PCSA
PCSA
12 hedge funds and large institutions have $75.9K invested in Processa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
$13.2K |
2 |
VF
Virtu Financial
New York
|
$21K |
3 |
AGM
Alpine Global Management
New York
|
$11K |
4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
$8.58K |
5 |
Jane Street
New York
|
$3.95K |
Top Sellers
1 |
AC
Armistice Capital
New York
|
$0 |
2 |
MMA
Miracle Mile Advisors
Los Angeles,
California
|
$0 |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
$505 |